Trial
NCT02635243
A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sanofi
Collaborators
—
Condition
Type 1 Diabetes Mellitus
Intervention
SAR438544
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-02